Founded in 2001, VI Partners is Switzerland's longest-established venture capital firm focused on early-stage life science and technology, built on close ties to ETH Zurich and EPFL through tech-transfer offices and backed by an investor base that includes ETH Zurich and major corporates like ABB, UBS, Nestlé and Sulzer, alongside an evergreen fund structure that recycles capital rather than following the typical 10-year VC model. This academic-to-industry pipeline has produced repeated large exits, including 2025's billion-dollar acquisitions of Nexthink and Araris Biotech, both of which grew out of Swiss university research.